Screening of Precancerous Gastric Lesions by Serum Pepsinogen, Gastrin-17, Anti-Helicobacter Pylori and Anti-Caga Antibodies in Dyspeptic Patients over 50 years Old in Guilan Province, North of Iran

被引:12
|
作者
Mansour-Ghanaei, Fariborz [1 ]
Joukar, Farahnaz [1 ]
Rajpout, Yaghoub [3 ]
Hasandokht, Tolou [2 ]
机构
[1] Guilan Univ Med Sci, GLDRC, Rasht, Iran
[2] Guilan Univ Med Sci, Dept Community Med, Rasht, Iran
[3] Jahrom Univ Med Sci, Dept Internal Med, Jahrom, Iran
关键词
Pepsinogen I; gastrin-17; Helicobacter pylori antibodies; precancerous gastric lesion; ATROPHIC GASTRITIS; CANCER; RISK; EPIDEMIOLOGY; INFECTION; DIAGNOSIS; ULCER;
D O I
10.7314/APJCP.2014.15.18.7635
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The aim of this study was to investigate the value of serum gastric markers to differentiate between patients with precancerous lesions and nonatrophic chronic gastritis. Materials and Methods: Serum samples of 128 patients with dyspepsia who were candidates for endoscopic examination were tested for pepsinogen (PG I and PG II), PG I/II ratio, gastrin 17(G-17), anti-Helicobacter pylori (anti-H pylori) and anti-CagA antibodies. Two sample t-tests, chi-square tests and Pearson's correlation analyses were used for analysis using SPSS (version 20). Results: PGI, PG I/II ratio values were decreased significantly in the precancerous lesion group (0.05, 0.001 respectively). The frequency of H pylori infection was significantly (p=0.03) different between the two groups of the study. Conclusions: We suggest PGI and the PG I/II ratio as valuable markers for screening of premalignant gastric lesions.
引用
收藏
页码:7635 / 7638
页数:4
相关论文
共 7 条
  • [1] SERUM PEPSINOGEN I AND II, GASTRIN-17, AND ANTI-HELICOBACTER PYLORI ANTIBODIES IN THE MANAGEMENT OF DYSPEPTIC SYMPTOMS
    de Bortoli, N.
    Maltinti, S.
    Bellini, M.
    Ceccarelli, L.
    Costa, F.
    Merlo, A.
    Mumolo, M. G.
    Ciancia, E.
    Praiano, F.
    Ricchiuti, A.
    Zullino, S.
    Marchi, S.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S140 - S140
  • [2] Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care
    Germaná, B
    Di Mario, F
    Cavallaro, LG
    Moussa, AM
    Lecis, P
    Liatoupolou, S
    Comparato, G
    Carloni, C
    Bertiato, G
    Battiestel, M
    Papa, N
    Aragona, G
    Cavestro, GM
    Iori, V
    Merli, R
    Bertolini, S
    Caruana, P
    Franzé, A
    DIGESTIVE AND LIVER DISEASE, 2005, 37 (07) : 501 - 508
  • [3] Analysis of gastric atrophy induced by Helicobacter pylori (H. pylori) infection using serum anti-Helicobacter pylori antibody, anti-Caga antibody, and pepsinogen status
    Yamaji, Y
    Shibata, W
    Watabe, H
    Yanai, A
    Hirata, Y
    Mitsuno, Y
    Maeda, S
    Yoshida, H
    Kawabe, T
    Omata, M
    GASTROENTEROLOGY, 2003, 124 (04) : A424 - A424
  • [4] Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies
    Cao, Qin
    Ran, Zhi Hua
    Xiao, Shu Dong
    JOURNAL OF DIGESTIVE DISEASES, 2007, 8 (01) : 15 - 22
  • [5] Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis
    Zagari, R. M.
    Rabitti, S.
    Greenwood, D. C.
    Eusebi, L. H.
    Vestito, A.
    Bazzoli, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (07) : 657 - 667
  • [6] Evaluating Gastric Cancer Risk by Using Serum Anti-Helicobacter pylori Antibodies and Serum Pepsinogen, Based on the ABC System, As a Mass Screening Tool for Gastric Cancer
    Kamada, Tomoari
    Yamashita, Naohito
    Inoue, Kazuhiko
    Murao, Takahisa
    Ishii, Manabu
    Fujita, Minoru
    Matsumoto, Hiroshi
    Tarumi, Ken-ichi
    Manabe, Noriaki
    Kusunoki, Hiroaki
    Shiotani, Akiko
    Hata, Jiro
    Haruma, Ken
    GASTROENTEROLOGY, 2015, 148 (04) : S416 - S416
  • [7] Pre-cancerous gastric lesions in Colombian patients: association with IL-1B-511, IL-1RN, IL-10-919, IL-10-1082, TNF-alpha-308 genes polymorphisms, and anti-Helicobacter pylori cagA IgG antibodies
    Martinez, Teresa
    Hernandez, Gustavo A.
    Mercedes Bravo, Maria
    Trujillo, Esperanza
    Perez-Garcia, Jesus
    Robayo, Juan C.
    Camorlinga, Margarita
    REVISTA COLOMBIANA DE CANCEROLOGIA, 2014, 18 (01): : 8 - 17